MANULIFE FINANCIAL CORP

Manulife’s pivot to AI and Southeast Asia offers a fresh edge for insurers amid shifting global capital flows and rising AI demand.

Shifts in Chinese foreign‑investment: investors favor application‑centric AI, regional banks, and global expansion while pulling back from traditional pharma.

Manulife’s 80% quota‑share reinsurance with Munich Re Life US cuts long‑term care risk, releases $3.2 bn in capital, and boosts future growth potential.

Insight on Manulife’s BTO & HEQ fund distributions reveals how insurers use capital‑allocation and tech‑driven underwriting to navigate climate, cyber, and regulatory risks.

Manulife’s 2027 trustee elections boost closed‑end fund governance, while its multimanager model and global WAM platform enhance alpha and risk control for institutional investors.

Manulife Series 11 preferred shares trade just above par, offering 6.2% yield and a regulated, income‑focused opportunity for institutional portfolios.

Manulife confirms fixed monthly payouts on its John Hancock Tax‑Advantaged and Premium Dividend Funds—predictable cash flow, clear tax notes, and ESG‑aligned strategy for institutional investors.

China markets tighten on CAR rules: Shanghai & Shenzhen dip, tech names like Zhongji Xuchuang attract huge margin inflows, and 18 new ETFs launch – insights for investors navigating tighter liquidity.

Manulife’s latest quarterly report reveals a balanced strategy that blends disciplined capital management, AI‑driven claims automation, and targeted investment in cyber‑risk and advanced manufacturing, positioning the insurer to thrive amid rising c…

Manulife launches the John Hancock Large‑Cap Opportunities ETF (JLCO), blending active U.S. equity growth with disciplined risk oversight to meet data‑driven insurance needs.